PT2078038E - Agentes tensioativos reconstituídos apresentando propriedades melhoradas - Google Patents

Agentes tensioativos reconstituídos apresentando propriedades melhoradas

Info

Publication number: PT2078038E
Authority: PT; Portugal
Prior art keywords: improved properties; reconstituted surfactants; reconstituted; surfactants; surfactant protein
Prior art date: 2006-10-13

Application number

PT78252129T

Other languages

English (en)

Inventor

Tore Curstedt

Jan Johansson

Bengt Robertson

Original Assignee

Chiesi Farma Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-10-13

Filing date

2007-09-28

Publication date

2013-12-12

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39079026&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT2078038(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2007-09-28 Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa

2013-12-12 Publication of PT2078038E publication Critical patent/PT2078038E/pt

Links

239000004094 surface-active agent Substances 0.000 title abstract 3
229920001184 polypeptide Polymers 0.000 abstract 2
102000004196 processed proteins & peptides Human genes 0.000 abstract 2
108090000765 processed proteins & peptides Proteins 0.000 abstract 2
108010007131 Pulmonary Surfactant-Associated Protein B Proteins 0.000 abstract 1
108010007125 Pulmonary Surfactant-Associated Protein C Proteins 0.000 abstract 1
102000007620 Pulmonary Surfactant-Associated Protein C Human genes 0.000 abstract 1
150000002632 lipids Chemical class 0.000 abstract 1
238000011321 prophylaxis Methods 0.000 abstract 1
208000023504 respiratory system disease Diseases 0.000 abstract 1
238000011282 treatment Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/395—Alveolar surfactant peptides; Pulmonary surfactant peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Pulmonology (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Epidemiology (AREA)
Immunology (AREA)
Biophysics (AREA)
Toxicology (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Medicinal Preparation (AREA)
Fire-Extinguishing Compositions (AREA)
Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)

PT78252129T 2006-10-13 2007-09-28 Agentes tensioativos reconstituídos apresentando propriedades melhoradas PT2078038E (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP06021521		2006-10-13

Publications (1)

Publication Number	Publication Date
PT2078038E true PT2078038E (pt)	2013-12-12

Family

ID=39079026

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT78252129T PT2078038E (pt)	2006-10-13	2007-09-28	Agentes tensioativos reconstituídos apresentando propriedades melhoradas

Country Status (35)

Country	Link
US (2)	US8183210B2 (pt)
EP (1)	EP2078038B1 (pt)
JP (2)	JP5405307B2 (pt)
KR (1)	KR101328851B1 (pt)
CN (2)	CN103169947B (pt)
AR (2)	AR063263A1 (pt)
AU (1)	AU2007306075B2 (pt)
BR (1)	BRPI0715317B1 (pt)
CA (1)	CA2666344C (pt)
CL (1)	CL2007002931A1 (pt)
CO (1)	CO6400235A2 (pt)
CY (1)	CY1114716T1 (pt)
DK (1)	DK2078038T3 (pt)
EA (1)	EA015802B1 (pt)
ES (1)	ES2438727T3 (pt)
GE (1)	GEP20125531B (pt)
HR (1)	HRP20140052T1 (pt)
IL (1)	IL198075A (pt)
JO (1)	JO2963B1 (pt)
MA (1)	MA31062B1 (pt)
ME (2)	MEP12109A (pt)
MX (1)	MX343064B (pt)
MY (1)	MY148127A (pt)
NO (1)	NO342038B1 (pt)
NZ (1)	NZ576189A (pt)
PE (1)	PE20081184A1 (pt)
PL (1)	PL2078038T3 (pt)
PT (1)	PT2078038E (pt)
RS (1)	RS53172B (pt)
SI (1)	SI2078038T1 (pt)
TN (1)	TN2009000099A1 (pt)
TW (1)	TWI388333B (pt)
UA (1)	UA94477C2 (pt)
WO (1)	WO2008044109A1 (pt)
ZA (1)	ZA200902481B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2008011559A2 (en)	2006-07-20	2008-01-24	University Of Rochester	Synthetic lung surfactant and use thereof
EP1997502A1 (en) *	2007-06-01	2008-12-03	CHIESI FARMACEUTICI S.p.A.	Reconstituted surfactants having improved properties
US8399406B2 (en) *	2009-06-05	2013-03-19	Chiesi Farmaceutici S.P.A.	Reconstituted surfactant composition containing analogs of surfactant protein B (SP-B) and surfactant protein C (SP-C)
CN101948526B (zh) *	2010-09-02	2012-12-05	华东理工大学	一种肺泡表面活性蛋白质(sp-b和sp-c)的分离纯化方法
WO2013120058A2 (en) *	2012-02-09	2013-08-15	University Of Rochester	Novel sp-b & sp-c peptides, synthetic lung surfactants, and use thereof
US20130303726A1 (en)	2012-04-17	2013-11-14	Chiesi Farmaceutici S.P.A.	Method for the preparation of surfactant peptides
US9074018B2 (en)	2012-11-21	2015-07-07	Chiesi Farmaceutici S.P.A.	Reconstituted pulmonary surfactants
EP3393489B1 (en)	2015-12-17	2021-09-01	Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center	Synthetic lung surfactant with enhanced stability and effectiveness
CA3016810C (en)	2016-03-07	2024-04-02	Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center	Compositions and methods for administering ppar.gamma. agonists, surfactant peptides and phospholipids
BR112019003673A2 (pt)	2016-08-24	2019-05-21	Chiesi Farmaceutici S.P.A.	formulação farmacêutica, uso de uma formulação farmacêutica e método para evitar o aumento da viscosidade durante o armazenamento de uma formulação farmacêutica
US12606609B2 (en)	2020-01-28	2026-04-21	Chiesi Farmaceutici S.P.A.	Polypeptides having improved properties
WO2022082082A2 (en) *	2020-10-16	2022-04-21	Sherwood Russ Lehrman	Lung treatment compositions
WO2025024609A1 (en) *	2023-07-25	2025-01-30	Biosuperior Technology, Inc.	Polypeptides for lung surfactant compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH08512056A (ja) *	1993-06-30	1996-12-17	ジェネンテク・インコーポレイテッド	リポソームの製造法
IT1308180B1 (it) *	1999-02-12	2001-12-07	Chiesi Farma Spa	Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante
US7065342B1 (en) *	1999-11-23	2006-06-20	Gofigure, L.L.C.	System and mobile cellular telephone device for playing recorded music
ITMI20021058A1 (it) *	2002-05-17	2003-11-17	Chiesi Farma Spa	Miscele di lipidi sintetici ottimizzate per la preparazione di un surfattante ricostituito
EP1481665A1 (en) *	2003-05-30	2004-12-01	CHIESI FARMACEUTICI S.p.A.	Novel lipid mixtures for synthetic surfactants
WO2008011559A2 (en) *	2006-07-20	2008-01-24	University Of Rochester	Synthetic lung surfactant and use thereof
EP1997502A1 (en) *	2007-06-01	2008-12-03	CHIESI FARMACEUTICI S.p.A.	Reconstituted surfactants having improved properties
EP2022798A1 (en)	2007-08-09	2009-02-11	CHIESI FARMACEUTICI S.p.A.	Synthetic pulmonary surfactant peptides

2007
- 2007-09-28 PT PT78252129T patent/PT2078038E/pt unknown
- 2007-09-28 ES ES07825212.9T patent/ES2438727T3/es active Active
- 2007-09-28 AU AU2007306075A patent/AU2007306075B2/en active Active
- 2007-09-28 KR KR1020097007008A patent/KR101328851B1/ko active Active
- 2007-09-28 BR BRPI0715317-1A patent/BRPI0715317B1/pt active IP Right Grant
- 2007-09-28 CA CA2666344A patent/CA2666344C/en active Active
- 2007-09-28 DK DK07825212.9T patent/DK2078038T3/da active
- 2007-09-28 ME MEP-121/09A patent/MEP12109A/xx unknown
- 2007-09-28 HR HRP20140052TT patent/HRP20140052T1/hr unknown
- 2007-09-28 SI SI200731393T patent/SI2078038T1/sl unknown
- 2007-09-28 ZA ZA200902481A patent/ZA200902481B/xx unknown
- 2007-09-28 MX MX2009003638A patent/MX343064B/es active IP Right Grant
- 2007-09-28 NZ NZ576189A patent/NZ576189A/en unknown
- 2007-09-28 MY MYPI20091454A patent/MY148127A/en unknown
- 2007-09-28 CN CN201310053516.8A patent/CN103169947B/zh active Active
- 2007-09-28 EP EP07825212.9A patent/EP2078038B1/en active Active
- 2007-09-28 JP JP2009531932A patent/JP5405307B2/ja active Active
- 2007-09-28 EA EA200900373A patent/EA015802B1/ru unknown
- 2007-09-28 GE GEAP200711224A patent/GEP20125531B/en unknown
- 2007-09-28 CN CN2007800382767A patent/CN101522711B/zh active Active
- 2007-09-28 ME MEP-2016-20A patent/ME02326B/me unknown
- 2007-09-28 WO PCT/IB2007/002841 patent/WO2008044109A1/en not_active Ceased
- 2007-09-28 RS RS20140037A patent/RS53172B/sr unknown
- 2007-09-28 UA UAA200903082A patent/UA94477C2/ru unknown
- 2007-09-28 PL PL07825212T patent/PL2078038T3/pl unknown
- 2007-10-11 TW TW096137965A patent/TWI388333B/zh active
- 2007-10-11 CL CL200702931A patent/CL2007002931A1/es unknown
- 2007-10-11 AR ARP070104520A patent/AR063263A1/es not_active Application Discontinuation
- 2007-10-11 JO JO2007436A patent/JO2963B1/en active
- 2007-10-11 PE PE2007001375A patent/PE20081184A1/es active IP Right Grant
2009
- 2009-03-25 TN TN2009000099A patent/TN2009000099A1/fr unknown
- 2009-04-07 IL IL198075A patent/IL198075A/en active IP Right Grant
- 2009-04-08 CO CO09036247A patent/CO6400235A2/es not_active Application Discontinuation
- 2009-04-13 US US12/422,581 patent/US8183210B2/en active Active
- 2009-04-14 NO NO20091441A patent/NO342038B1/no unknown
- 2009-05-08 MA MA31854A patent/MA31062B1/fr unknown
2012
- 2012-04-10 US US13/443,164 patent/US9238058B2/en active Active
2013
- 2013-08-02 JP JP2013161238A patent/JP2013241449A/ja active Pending
- 2013-12-11 CY CY20131101121T patent/CY1114716T1/el unknown
2018
- 2018-11-05 AR ARP180103211A patent/AR113422A2/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
JP5405307B2 (ja)	2014-02-05
ES2438727T3 (es)	2014-01-20
US8183210B2 (en)	2012-05-22
WO2008044109A1 (en)	2008-04-17
CN103169947B (zh)	2014-10-29
CO6400235A2 (es)	2012-03-15
MY148127A (en)	2013-02-28
JP2010505937A (ja)	2010-02-25
JO2963B1 (en)	2016-03-15
UA94477C2 (ru)	2011-05-10
RS53172B (sr)	2014-06-30
CN103169947A (zh)	2013-06-26
BRPI0715317A2 (pt)	2013-07-09
MX2009003638A (es)	2009-04-22
EP2078038A1 (en)	2009-07-15
US20130079275A1 (en)	2013-03-28
KR101328851B1 (ko)	2013-11-14
CY1114716T1 (el)	2016-10-05
HK1185274A1 (en)	2014-02-14
CL2007002931A1 (es)	2008-03-24
IL198075A0 (en)	2011-08-01
AU2007306075A1 (en)	2008-04-17
HK1134497A1 (en)	2010-04-30
NO342038B1 (no)	2018-03-19
TW200824705A (en)	2008-06-16
KR20090083892A (ko)	2009-08-04
NZ576189A (en)	2011-09-30
GEP20125531B (en)	2012-05-25
IL198075A (en)	2016-04-21
DK2078038T3 (da)	2013-12-02
MA31062B1 (fr)	2010-01-04
MX343064B (es)	2016-10-24
ME02326B (me)	2016-06-20
CA2666344C (en)	2017-04-18
SI2078038T1 (sl)	2014-02-28
US20100004173A1 (en)	2010-01-07
TN2009000099A1 (en)	2010-08-19
PL2078038T3 (pl)	2014-05-30
CA2666344A1 (en)	2008-04-17
TWI388333B (zh)	2013-03-11
BRPI0715317B1 (pt)	2021-10-05
MEP12109A (en)	2011-12-20
HRP20140052T1 (hr)	2014-02-28
EA200900373A1 (ru)	2009-10-30
AR063263A1 (es)	2009-01-14
CN101522711A (zh)	2009-09-02
US9238058B2 (en)	2016-01-19
JP2013241449A (ja)	2013-12-05
CN101522711B (zh)	2013-11-13
NO20091441L (no)	2009-06-23
AR113422A2 (es)	2020-04-29
EA015802B1 (ru)	2011-12-30
EP2078038B1 (en)	2013-11-20
PE20081184A1 (es)	2008-09-26
ZA200902481B (en)	2010-07-28
AU2007306075B2 (en)	2012-08-09

Publication	Publication Date	Title
MY148127A (en)	2013-02-28	Reconstituted surfactants having improved properties
MY159464A (en)	2017-01-13	Reconstituted surfactant composition containing analogs of surfactant protein b (sp-b) and surfactant protein c (sp-c)
MX2009012675A (es)	2009-12-14	Tensioactivos reconstituidos que tienen propiedades mejoradas.
UA95235C2 (en)	2011-07-25	Glucagon-like-peptide-2 (glp-2) analogues
TW200745334A (en)	2007-12-16	Compositions and methods for producing a composition
MX2010002716A (es)	2010-07-05	Uso de slit, nefrina, efrina o semaforina para el tratamiento de enfermedades de cartilago.
WO2009010968A3 (en)	2009-05-28	Disease treatment via antimicrobial peptides or their inhibitors
EP4374913A3 (en)	2024-08-14	Novel human serum albumin mutant
MX2010001543A (es)	2010-03-15	Peptidos de surfactante pulmonar sintetico.
AU2003251729A8 (en)	2004-01-19	Use of antibodies against flt-1 for the treatment of osteoporosis
TW200700085A (en)	2007-01-01	Endoparasiticidal compositions
MX2024002325A (es)	2024-05-23	Composiciones de lactoferrina y metodos de uso.
WO2006122162A3 (en)	2007-08-30	Use of peptides derived from the growth factor amp-18 for the treatment of mucositis
JO3046B1 (ar)	2016-09-05	اشكال متعددة من 7- )] 3-كلورو-6و11-ثنائي هيدرو -6-ميثيل ثنائي بنزو [1, 2][f,c] ثيازبين-11-يل)امينو[ حمض هباتونك S,S- ثنائي أوكسيد وطرق لتصنيعها و استخدامها.
ATE467643T1 (de)	2010-05-15	Peptide mit proliferationshemmender wirkung
GB0616061D0 (en)	2006-09-20	Peptides and uses thereof
TW200517125A (en)	2005-06-01	Pharmaceutical composition for treatment of solid cancers
GB201019467D0 (en)	2010-12-29	Therapeutic agent
MX2024002323A (es)	2024-05-31	Composiciones de lactoferrina y metodos de uso.
SG170757A1 (en)	2011-05-30	Polypeptide having esterase activity and recombinant esterase and use thereof
AU2346301A (en)	2001-05-08	Use of parvoviruses for improving the general condition of tumour patients or patients having chronic or consumptive diseases
TW200801033A (en)	2008-01-01	Process for the manufacture of peptide facilitators of reverse cholesterol transport
UA96003C2 (en)	2011-09-26	PHARMACEUTICAL COMPOSITION [Aib8,35]hGLP-1(7-36)NH2
DE602007009797D1 (de)	2010-11-25	Antitumorheilmittel, Medikament, Zusammensetzung und Verwendung davon
WO2007070907A3 (en)	2007-10-04	Therapeutic compositions